88 related articles for article (PubMed ID: 27600447)
21. Rate of memory decline in AD is related to education and occupation: cognitive reserve?
Stern Y; Albert S; Tang MX; Tsai WY
Neurology; 1999 Dec; 53(9):1942-7. PubMed ID: 10599762
[TBL] [Abstract][Full Text] [Related]
22. Vitamin E for Alzheimer's disease and mild cognitive impairment.
Isaac MG; Quinn R; Tabet N
Cochrane Database Syst Rev; 2008 Jul; (3):CD002854. PubMed ID: 18646084
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal patterns of unawareness of memory deficits in mild Alzheimer's disease.
Akai T; Hanyu H; Sakurai H; Sato T; Iwamoto T
Geriatr Gerontol Int; 2009 Mar; 9(1):16-20. PubMed ID: 19260975
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
25. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
De Jesus Moreno Moreno M
Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
[TBL] [Abstract][Full Text] [Related]
26. Cognitive performance on the Alzheimer's Disease Assessment Scale: effect of education.
Doraiswamy PM; Krishen A; Stallone F; Martin WL; Potts NL; Metz A; DeVeaugh-Geiss J
Neurology; 1995 Nov; 45(11):1980-4. PubMed ID: 7501145
[TBL] [Abstract][Full Text] [Related]
27. Effects of educational attainment and occupational status on cognitive and functional decline in persons with Alzheimer-type dementia.
Fritsch T; McClendon MJ; Smyth KA; Ogrocki PK
Int Psychogeriatr; 2002 Dec; 14(4):347-63. PubMed ID: 12670057
[TBL] [Abstract][Full Text] [Related]
28. Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.
Cacciamani F; Tandetnik C; Gagliardi G; Bertin H; Habert MO; Hampel H; Boukadida L; Révillon M; Epelbaum S; Dubois B;
J Alzheimers Dis; 2017; 59(2):753-762. PubMed ID: 28671134
[TBL] [Abstract][Full Text] [Related]
29. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
Wattmo C; Wallin ÅK
Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
[TBL] [Abstract][Full Text] [Related]
30. A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's Disease.
Ketter N; Liu E; Di J; Honig LS; Lu M; Novak G; Werth J; LePrince Leterme G; Shadman A; Brashear HR
J Prev Alzheimers Dis; 2016; 3(4):192-201. PubMed ID: 29199321
[TBL] [Abstract][Full Text] [Related]
31. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
32. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
Wattmo C; Minthon L; Wallin ÅK
Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
[TBL] [Abstract][Full Text] [Related]
33. Occupational Attainment as Risk Factor for Progression from Mild Cognitive Impairment to Alzheimer's Disease: A CREDOS Study.
Myung W; Lee C; Park JH; Woo SY; Kim S; Kim S; Chung JW; Kang HS; Lim SW; Choi J; Na DL; Kim SY; Lee JH; Han SH; Choi SH; Kim SY; Carroll BJ; Kim DK
J Alzheimers Dis; 2017; 55(1):283-292. PubMed ID: 27662289
[TBL] [Abstract][Full Text] [Related]
34. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale--cognitive subscale].
Pákáski M; Drótos G; Janka Z; Kálmán J
Orv Hetil; 2012 Mar; 153(12):461-6. PubMed ID: 22411219
[TBL] [Abstract][Full Text] [Related]
35. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
[TBL] [Abstract][Full Text] [Related]
37. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
Morris JC; Cyrus PA; Orazem J; Mas J; Bieber F; Ruzicka BB; Gulanski B
Neurology; 1998 May; 50(5):1222-30. PubMed ID: 9595967
[TBL] [Abstract][Full Text] [Related]
38. The Brookline Early Education Project: a 25-year follow-up study of a family-centered early health and development intervention.
Palfrey JS; Hauser-Cram P; Bronson MB; Warfield ME; Sirin S; Chan E
Pediatrics; 2005 Jul; 116(1):144-52. PubMed ID: 15995045
[TBL] [Abstract][Full Text] [Related]
39. Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial.
Sink KM; Espeland MA; Castro CM; Church T; Cohen R; Dodson JA; Guralnik J; Hendrie HC; Jennings J; Katula J; Lopez OL; McDermott MM; Pahor M; Reid KF; Rushing J; Verghese J; Rapp S; Williamson JD;
JAMA; 2015 Aug; 314(8):781-90. PubMed ID: 26305648
[TBL] [Abstract][Full Text] [Related]
40. Donepezil for vascular cognitive impairment.
Malouf R; Birks J
Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
